Benitec Biopharma (BNTC) Invested Capital (2019 - 2025)
Benitec Biopharma has reported Invested Capital over the past 7 years, most recently at $187.4 million for Q4 2025.
- Quarterly results put Invested Capital at $187.4 million for Q4 2025, up 18736000.0% from a year ago — trailing twelve months through Dec 2025 was $187.4 million (up 18736000.0% YoY), and the annual figure for FY2025 was $97.3 million, up 105.92%.
- Invested Capital reached $187.4 million in Q4 2025 per BNTC's latest filing, up from $93.6 million in the prior quarter.
- Across five years, Invested Capital topped out at $187.4 million in Q4 2025 and bottomed at -$219.4 million in Q1 2025.
- Median Invested Capital over the past 5 years was $11.2 million (2021), compared with a mean of $7.8 million.
- Peak annual rise in Invested Capital hit 18736000.0% in 2025, while the deepest fall reached 2007.57% in 2025.
- Over 5 years, Invested Capital stood at $10.8 million in 2021, then dropped by 17.0% to $9.0 million in 2022, then surged by 72.0% to $15.5 million in 2023, then crashed by 99.99% to $1000.0 in 2024, then soared by 18736000.0% to $187.4 million in 2025.
- Business Quant data shows Invested Capital for BNTC at $187.4 million in Q4 2025, $93.6 million in Q3 2025, and $97.3 million in Q2 2025.